TI-0093

N/A

Report date: 2026/05/12 09:17:21

Base Information

Drug NameTI-0093
Drug Alias NameTI-0093TI0093
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > Circular RNA vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Gene therapy > LNP +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisUterine Cervical Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTherorna Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTherorna Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisUterine Cervical Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A